Tag: chemotherapy market opportunities

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Chemotherapy Market Growth Potential: How Will Market Size Shift Through 2030?

The chemotherapy market has seen considerable expansion in recent years. It is anticipated to increase from $37.27 billion in 2025 to $41.95 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. This historical growth can be attributed to the rising occurrence of cancer, increased government investment in healthcare, ongoing advancements in chemotherapeutic drugs, the expansion of hospital infrastructure, and the wider adoption of intravenous chemotherapy.

The chemotherapy market size is anticipated to undergo substantial growth over the upcoming years. It is projected to expand to $68.44 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This expansion during the forecast period is fueled by elements such as the broader application of precision medicine, the creation of targeted therapies, enhanced understanding of home-based chemotherapy, the incorporation of digital health tools, and a surging need for combination therapies. Notable trends expected in this timeframe include customized chemotherapy regimens, the uptake of oral chemotherapy, the advancement of combination drug therapies, the provision of chemotherapy services at home, and sophisticated infusion device technologies.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=36333901&type=smp&name=Chemotherapy%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Chemotherapy Market Demand Drivers: What’s Powering Industry Growth?

The anticipated rise in cancer cases is expected to drive the expansion of the chemotherapy market in the future. Cancer is a condition where certain body cells multiply uncontrollably and spread to other regions. Chemotherapy utilizes powerful chemicals, either singly or in combination, to treat cancer by targeting and eliminating rapidly growing cancerous cells. A higher incidence of cancer will consequently increase the demand for chemotherapy. For instance, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported in February 2024 a projection of over 35 million new cancer cases in 2025. This represents a 77% increase from the estimated 20 million cases recorded in 2022. Therefore, the growing prevalence of cancer is a significant factor propelling the chemotherapy market.

Chemotherapy Market Breakdown By Product Type And Application

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

Chemotherapy Market Innovation Trends: What Developments Are Reshaping The Industry?

Leading companies in the chemotherapy market are primarily focused on forging strategic alliances to commercialize the introduction of inventive medical devices that assist in chemotherapy services. These collaborations seek to utilize the capabilities and resources of each involved party to expedite advancements in cancer treatment, elevate patient outcomes, and address existing medical gaps. For example, in March 2023, EVERSANA, a US-based entity providing global services to the life sciences industry, entered into a partnership with ChemoMouthpiece LLC, a US-based medical device firm. This agreement was made to support the launch and commercialization of its medical device, the Chemo Mouthpiece, intended for oncology patients throughout the United States. The Chemo Mouthpiece is essentially an intraoral ice pack that delivers cryotherapy to the oral cavity of a patient receiving chemotherapy. It serves to prevent and alleviate oral mucositis, a common and very painful side effect of chemotherapy.

Chemotherapy Market Company Landscape And Competitive Strategy

Major companies operating in the chemotherapy market are GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

View The Full Chemotherapy Market Report:

https://thebusinessresearchcompany.com/report/chemotherapy-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Chemotherapy Market Regional Analysis And Top Geography

North America was the largest region in the chemotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Chemotherapy Market Expansion From $41.95 Billion In 2026 To $68.43 Billion In 2030

Over recent years, the chemotherapy market has undergone a rapid expansion in size, with its value projected to rise from $37.27 billion in 2025 to $41.95 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.5%. This historical growth was driven by factors including a higher incidence of cancer cases, growing government spending on healthcare services, progress in the development of chemotherapeutic drugs, improvements in hospital facilities, and the increased use of intravenous chemotherapy treatments.

The size of the chemotherapy market is forecasted to expand quickly over the coming years. By 2030, its value is projected to reach $68.44 billion, reflecting a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period stems from the broadening scope of precision medicine, progress in creating targeted therapies, heightened awareness of home-based chemotherapy options, the incorporation of digital health tools, and a growing preference for combination treatments. Key developments shaping the period include the rise of individualized chemotherapy schedules, an increased uptake of oral chemotherapeutic agents, the advancement of combination drug therapies, the provision of chemotherapy in home settings, and the evolution of sophisticated infusion device technologies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Chemotherapy Market Expansion Drivers: What Is Shaping Future Growth?

Rising rates of cancer are anticipated to accelerate the expansion of the chemotherapy market in the coming period. This condition occurs when abnormal body cells multiply without control and invade other tissues. Treatment involves the use of potent chemicals, either alone or in combination, aimed at destroying rapidly dividing cancer cells. As cancer becomes more common, the need for chemotherapy treatments grows accordingly. Data from the World Health Organization, a United Nations agency headquartered in Switzerland, released in February 2024, projects that by 2025 there will be over 35 million new cancer diagnoses, representing a 77% surge compared to the approximately 20 million cases estimated for 2022. Consequently, the upward trend in cancer prevalence is fueling demand within the chemotherapy sector.

Chemotherapy Market Segment Landscape And Growth Potential

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

Chemotherapy Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Leading market players within the chemotherapy sector are actively pursuing strategic collaborations to facilitate the commercial rollout of advanced medical devices designed to enhance chemotherapy services. These alliances are crafted to combine the distinct capabilities and resources of each entity, aiming to expedite advancements in cancer care, elevate patient outcomes, and tackle unmet therapeutic needs. A case in point occurred in March 2023 when EVERSANA, a US-based life sciences service provider, joined forces with ChemoMouthpiece LLC, an American medical device firm, to back the market introduction and commercialization of the Chemo Mouthpiece, a device intended to aid oncology patients nationwide. This intraoral ice pack administers cryotherapy to the oral cavity of individuals undergoing chemotherapy, serving to both prevent and treat oral mucositis, a frequent and severe side effect of the treatment.

Chemotherapy Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the chemotherapy market are GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

Access The Complete Chemotherapy Market Report:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Chemotherapy Market Regional Distribution: Which Areas Drive Market Expansion?

North America was the largest region in the chemotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Chemotherapy Market Projected To Expand During 2026–2030?

The chemotherapy market has experienced significant expansion in recent years. It will grow from $37.27 billion in 2025 to $41.95 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. Historically, this expansion can be attributed to factors such as the increasing prevalence of cancer, rising government healthcare expenditure, advancements in chemotherapeutic drugs, the growth of hospital infrastructure, and the adoption of intravenous chemotherapy.

The chemotherapy market is anticipated to undergo significant expansion in the near future. Its valuation is projected to reach $68.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This growth during the forecast period is primarily driven by the broader adoption of precision medicine, the development of targeted therapies, increased awareness regarding home-based chemotherapy options, the integration of digital health solutions, and a rising demand for combination treatments. Noteworthy trends for the upcoming period include personalized chemotherapy regimens, the embrace of oral chemotherapy, the advancement of combination drug therapies, the delivery of chemotherapy in home settings, and innovations in advanced infusion device technologies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

Which Growth Drivers Are Expected To Support The Chemotherapy Market Forward?

The rising incidence of cancer is anticipated to drive the expansion of the chemotherapy market in the future. Cancer is characterized by the uncontrolled proliferation of certain body cells which then spread to other regions. Chemotherapy involves the use of potent chemicals, either singly or combined, to treat cancer by eradicating rapidly multiplying cancer cells. Consequently, the growing occurrence of cancer will boost the need for chemotherapy. For example, the World Health Organization, a United Nations specialized agency based in Switzerland, reported in February 2024 that more than 35 million new cancer cases are projected for 2025, representing a 77% surge from the estimated 20 million cases in 2022. Thus, the escalating cancer prevalence is a key factor propelling the chemotherapy market.

How Is Segment Classification Applied In The Chemotherapy Market?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

What Trends Are Influencing The Chemotherapy Market?

Leading companies in the chemotherapy market are prioritizing the formation of strategic partnerships to facilitate the commercial launch of innovative medical devices that assist in chemotherapy services. These alliances aim to harness the individual strengths and resources of each partner to accelerate breakthroughs in cancer treatment, improve patient outcomes, and address existing unmet medical needs. For instance, in March 2023, EVERSANA, a US-based global services provider for the life sciences industry, entered into a partnership with ChemoMouthpiece LLC, a US-based medical device company. This collaboration was established to support the launch and commercialization of its medical device, the Chemo Mouthpiece, intended to help oncology patients across the United States. The Chemo Mouthpiece functions as an intraoral ice pack, delivering cryotherapy to the oral cavity of a patient undergoing chemotherapy, effectively preventing and treating oral mucositis, a common and extremely painful chemotherapy side effect.

Which Organizations Are Involved In The Chemotherapy Market?

Major companies operating in the chemotherapy market are GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

Access The Complete Chemotherapy Market Report:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Which Region Leads The Chemotherapy Market By Size?

North America was the largest region in the chemotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Chemotherapy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

Browse Through More Reports Similar to the Global Chemotherapy Market 2026, By The Business Research Company

Chemotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Chemotherapy At Home Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-at-home-services-global-market-report

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Chemotherapy Market Grow Between 2026 And 2030?

The chemotherapy market size has seen rapid expansion in recent years. It is anticipated to increase from $37.27 billion in 2025 to $41.95 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.5%. The historical growth of this market can be linked to factors such as the increasing occurrence of cancer, greater government spending on healthcare, developments in chemotherapeutic medicines, the expansion of hospital infrastructure, and the widespread use of intravenous chemotherapy.

The chemotherapy market is anticipated to show significant growth in the upcoming period. Its value is forecast to reach $68.44 billion by 2030, achieving a compound annual growth rate (CAGR) of 13.0%. This expansion during the forecast timeframe is attributable to several factors, including the spread of precision medicine, the creation of targeted therapies, greater understanding of home-based chemotherapy options, the adoption of digital health solutions, and the increasing need for combination therapies. Key developments expected during this period involve personalized chemotherapy regimens, the rise of oral chemotherapy adoption, the advancement of combination drug therapies, at-home chemotherapy delivery, and innovations in infusion device technologies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

Which Primary Drivers Are Impacting The Chemotherapy Market Growth?

The projected rise in cancer cases is anticipated to fuel expansion within the chemotherapy market. Cancer is a medical condition characterized by the uncontrolled proliferation of certain body cells and their spread to distinct areas. Chemotherapy involves the application of potent chemical agents, either singly or in combination, to manage cancer by eradicating rapidly multiplying cancer cells. Consequently, a growing prevalence of cancer is set to boost the need for chemotherapy treatments. A notable example is the projection made in February 2024 by the World Health Organization, a specialized agency of the United Nations based in Switzerland, indicating that new cancer cases will surpass 35 million in 2025. This represents a substantial 77% increase from the approximate 20 million cases recorded in 2022. These statistics underscore how the escalating incidence of cancer is a key driver for the chemotherapy market.

How Is Segmentation Applied In The Chemotherapy Market Segment Analysis?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

Which Trends Are Guiding The Direction Of The Chemotherapy Market?

Leading companies in the chemotherapy market are concentrating on forming strategic alliances to facilitate the introduction of advanced medical devices that support chemotherapy services. These collaborations aim to harness the strengths and resources of each entity to accelerate progress in cancer treatment, improve patient outcomes, and address existing medical gaps. For instance, in March 2023, EVERSANA, a US-based global service provider for the life sciences industry, joined forces with ChemoMouthpiece LLC, a US-based medical device firm, to assist with the launch and commercialization of its medical device, the Chemo Mouthpiece, designed for oncology patients throughout the United States. The Chemo Mouthpiece is an intraoral ice pack that delivers cryotherapy to the oral cavity of patients undergoing chemotherapy. It is effective in preventing and treating oral mucositis, a prevalent and intensely painful side effect of chemotherapy.

Who Are The Companies Participating In The Chemotherapy Market Environment?

Major companies operating in the chemotherapy market are GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

Get The Full Chemotherapy Market Report:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Which Geographic Region Dominates The Chemotherapy Market?

North America was the largest region in the chemotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Chemotherapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Browse Through More Reports Similar to the Global Chemotherapy Market 2026, By The Business Research Company

Chemotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Chemotherapy At Home Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-at-home-services-global-market-report

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Chemotherapy Market By The End Of 2030?

The chemotherapy market has witnessed rapid expansion in recent years. This market is forecast to increase from $37.27 billion in 2025 to $41.95 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. Historically, this market’s growth can be attributed to the rising prevalence of cancer, increased government expenditure on healthcare, advancements in chemotherapeutic drugs, the expansion of hospital infrastructure, and the adoption of intravenous chemotherapy.

The chemotherapy market size is poised for substantial expansion in the coming years. It is projected to reach $68.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period is fueled by several factors, including the increasing reach of precision medicine, advancements in targeted therapies, growing understanding of home-based chemotherapy options, the incorporation of digital health solutions, and a rising need for combination therapies. Significant trends during this period are anticipated to encompass customized chemotherapy regimens, the adoption of oral chemotherapy, the creation of combination drug therapies, the provision of home-based chemotherapy, and sophisticated infusion device technologies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

Which Market Drivers Are Supporting The Expansion Of The Chemotherapy Market?

A rising incidence of cancer is anticipated to stimulate the expansion of the chemotherapy market. Cancer is characterized by the uncontrolled proliferation of certain body cells which subsequently spread to other regions. Chemotherapy involves the application of potent chemical agents, individually or in conjunction, to combat cancer by eradicating rapidly multiplying cancerous cells. Consequently, the growing number of cancer cases will elevate the need for chemotherapy treatments. As an illustration, the World Health Organization, a specialized agency of the United Nations situated in Switzerland, indicated in February 2024 that the year 2025 is forecast to see over 35 million new cancer diagnoses, marking a 77% surge from the approximately 20 million cases recorded in 2022. Thus, the expanding prevalence of cancer is a significant impetus for the chemotherapy market.

Which Segment Classifications Shape The Chemotherapy Market?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

How Are Trends Impacting The Chemotherapy Market?

Major companies within the chemotherapy market are increasingly forming strategic alliances to enable the market entry of innovative medical devices designed to support chemotherapy services. These collaborations aim to utilize each party’s unique strengths and resources to accelerate advancements in cancer treatment, improve patient health outcomes, and address existing medical needs. For example, in March 2023, EVERSANA, a US-based provider of global services to the life sciences industry, partnered with ChemoMouthpiece LLC, a US-based medical device company, to facilitate the introduction and commercialization of its medical device, the Chemo Mouthpiece, to assist oncology patients across the United States. The Chemo Mouthpiece is an intraoral ice pack that delivers cryotherapy directly to the oral cavity of patients undergoing chemotherapy. Its purpose is to prevent and alleviate oral mucositis, a frequent and extremely painful side effect of chemotherapy.

Which Companies Are Expanding Their Footprint In The Chemotherapy Market?

Major companies operating in the chemotherapy market are GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

Read the full chemotherapy market report here:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

How Is The Chemotherapy Market Distributed Across Key Geographic Regions?

North America was the largest region in the chemotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Chemotherapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9219&type=smp

Browse Through More Reports Similar to the Global Chemotherapy Market 2026, By The Business Research Company

Chemotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Chemotherapy At Home Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-at-home-services-global-market-report

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the chemotherapy market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Chemotherapy Market between 2026 and 2030?

The chemotherapy market has witnessed rapid growth in recent years. It is anticipated to expand from $37.27 billion in 2025 to $41.95 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.5%. This historical growth can be ascribed to several factors, including the increasing prevalence of cancer, rising government healthcare expenditure, advancements in chemotherapeutic drugs, the expansion of hospital infrastructure, and the adoption of intravenous chemotherapy.

The chemotherapy market is projected for substantial expansion in the coming years. This market is anticipated to reach $68.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This projected growth during the forecast period stems from the broader adoption of precision medicine, the progression of targeted therapies, heightened understanding of home-based chemotherapy options, the incorporation of digital health solutions, and an increasing need for combination therapies. Key developments expected over the forecast period encompass tailored chemotherapy regimens, the embrace of oral chemotherapy, advancements in combination drug therapy, the provision of home-based chemotherapy, and sophisticated infusion device technologies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

Which Drivers Are Expected To Impact The Chemotherapy Market During The Forecast Period?

The increasing prevalence of cancer is projected to fuel the expansion of the chemotherapy market going forward. Cancer describes a disease where some body cells grow uncontrollably and spread to other areas. Chemotherapy employs powerful chemicals, either alone or in combination, to treat cancer by destroying fast-growing cancer cells. Additionally, a rise in cancer prevalence will increase the demand for chemotherapy. For instance, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, over 35 million new cancer cases are anticipated in 2025, marking a 77% increase from the estimated 20 million cases in 2022. Therefore, the growing incidence of cancer is a primary driver for the chemotherapy market.

Which Segments Are Driving Activity In The Chemotherapy Market?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

Which Trends Are Guiding The Evolution Of The Chemotherapy Market?

Key players in the chemotherapy market are concentrating on forming strategic alliances to commercialize new medical devices that facilitate chemotherapy services. These collaborations are designed to utilize the collective strengths and resources of each entity, thereby accelerating progress in cancer treatment, enhancing patient results, and addressing existing medical needs. For example, in March 2023, EVERSANA, a US-based global services provider to the life sciences industry, joined forces with ChemoMouthpiece LLC, a US-based medical device company, to back the launch and commercialization of its medical device, the Chemo Mouthpiece, for oncology patients throughout the United States. The Chemo Mouthpiece is an intraoral ice pack that delivers cryotherapy to the oral cavity of patients undergoing chemotherapy, effectively preventing and treating oral mucositis, a prevalent and very painful chemotherapy side effect.

Which Leading Companies Dominate The Chemotherapy Market Share?

Major companies operating in the chemotherapy market are GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

How Does The Chemotherapy Market Perform Across Major Global Regions?

North America was the largest region in the chemotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Chemotherapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9219&type=smp

Browse Through More Reports Similar to the Global Chemotherapy Market 2026, By The Business Research Company

Chemotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Chemotherapy At Home Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-at-home-services-global-market-report

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the chemotherapy market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Chemotherapy Market And What Value Is Projected For 2029?

The chemotherapy market has experienced substantial expansion in recent years. This market is projected to expand from $34 billion in 2024 to $37.27 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.6%. Historically, this expansion has been driven by factors such as a rise in cancer incidence, improvements in cancer diagnosis, breakthroughs in drug development, increased clinical trial activity, better access to healthcare, and effective awareness campaigns.

The chemotherapy market is anticipated to experience substantial expansion over the coming years. Projections indicate it will reach a value of $60.31 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.8%. This projected increase during the forecast period is fueled by factors such as the incorporation of immunotherapy, wider acceptance of biosimilars, growth in developing markets, advancements in genomic profiling, improvements in supportive care, and streamlined regulatory processes. Key developments expected within this timeframe encompass digital health solutions, customized medicine approaches, ongoing research in oncology, the incorporation of artificial intelligence (AI), progress in nanotechnology, and the administration of chemotherapy in home settings.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

What Factors Are Boosting The Chemotherapy Market?

The anticipated rise in cancer cases is projected to boost the expansion of the chemotherapy market in the future. Cancer is defined as an illness where certain bodily cells proliferate without control and disseminate to different areas. Chemotherapy involves the use of potent chemicals, either individually or together, to treat cancer by eliminating rapidly multiplying cancer cells. Furthermore, a higher incidence of cancer will lead to a greater need for chemotherapy. For example, data from the American Cancer Society Inc., a US-based non-profit health organization, indicates that 1.9 million new cancer diagnoses are anticipated in the US in 2023, up from 1.8 million new cases recorded in 2020. Moreover, in the US, cancer is projected to cause 609,820 deaths in 2023, compared to 606,520 Americans who were expected to die from the disease in 2020. Consequently, the rising occurrence of cancer is a key factor propelling the chemotherapy market.

What Are The Core Segmentation Criteria In The Chemotherapy Market?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

Which Emerging Trends Are Reshaping The Chemotherapy Market Landscape?

Leading companies in the chemotherapy market are concentrating on introducing advanced solutions, such as chemotherapy infusion pumps, to gain a competitive advantage. Chemotherapy infusion pumps are devices engineered to deliver chemotherapy drugs directly into the bloodstream via an IV line. These pumps facilitate the administration of chemotherapy in a controlled manner, enabling a slow and steady infusion of drugs into the body. For instance, in March 2022, Shanghai MicroPort Lifesciences Co. Ltd., a medical technology developer and manufacturer based in China, secured marketing approval from China’s National Medical Products Administration (NMPA) for its AutoEx Chemotherapy Infusion Pump. The AutoEx pump is designed for the continuous or intermittent delivery of chemotherapy drugs to patients with malignancies. Its goal is to maintain optimal drug concentration in the bloodstream, thereby enhancing the effectiveness of cancer treatment while concurrently reducing adverse effects. The device features a dual CPU control system and a dual power supply, which ensures high precision in drug delivery. This design ultimately improves patient comfort and safety during chemotherapy.

Which Players Are Shaping The Competitive Landscape Of The ChemotherapyXX Market?

Major companies operating in the chemotherapy market include GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

What Regional Trends Are Shaping Growth In The Chemotherapy Market?

North America was the largest region in the chemotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9219&type=smp

Browse Through More Reports Similar to the Global Chemotherapy Market 2025, By The Business Research Company

Pain Management Devices And Therapies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Metabolomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Isothermal Nucleic Acid Amplification Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Chemotherapy Market Size During 2025–2029?

The chemotherapy market size has observed substantial growth in recent years. It is anticipated to expand from $34 billion in 2024 to $37.27 billion in 2025, registering a compound annual growth rate (CAGR) of 9.6%. This historical growth can be linked to cancer incidence increase, advancements in cancer diagnosis, innovation in drug development, clinical trial activity, access to healthcare, and awareness campaigns.

The chemotherapy market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $60.31 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.8%. The expansion during the forecast period is primarily driven by factors such as the incorporation of immunotherapy, the uptake of biosimilars, the development of emerging markets, advancements in genomic profiling, enhancements in supportive care, and streamlined regulatory processes. Key trends foreseen for this period encompass digital health innovations, tailored personalized medicine approaches, ongoing research in oncology, the incorporation of artificial intelligence (AI), progress in nanotechnology, and the provision of chemotherapy at home.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

Which Industry Drivers Are Expected To Accelerate The Chemotherapy Market From 2025 To 2029?

The rising incidence of cancer is projected to fuel the expansion of the chemotherapy market moving forward. Cancer is defined as a condition where certain body cells multiply uncontrollably and disseminate to various regions of the body. Chemotherapy involves the use of potent chemical agents, either singly or together, to treat cancer by eliminating rapidly dividing cancer cells. Furthermore, the growing occurrence of cancer will boost the need for chemotherapy. As an example, the American Cancer Society Inc., a US-based non-profit health organization, reports that in 2023, the US is projected to see 1.9 million new cancer diagnoses, an increase from the 1.8 million new cases diagnosed in 2020. Additionally, in the US, 609,820 fatalities due to cancer are forecast for 2023, compared to an estimated 606,520 Americans who succumbed to cancer in 2020. Consequently, the increasing cancer prevalence is propelling the chemotherapy market.

How Is The Chemotherapy Market Segmented?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

What Long-Term Trends Will Shape The Future Growth Of The Chemotherapy Industry?

Leading corporations within the chemotherapy sector are prioritizing the introduction of groundbreaking solutions, such as chemotherapy infusion pumps, to secure a competitive advantage. Chemotherapy infusion pumps are instruments designed to administer chemotherapy medications directly into the bloodstream through an intravenous (IV) line. These pumps facilitate the controlled administration of chemotherapy, enabling a gradual and consistent infusion of drugs into the body. For instance, in March 2022, Shanghai MicroPort Lifesciences Co. Ltd., a China-based developer and manufacturer of medical technology, obtained marketing authorization from China’s National Medical Products Administration (NMPA) for its AutoEx Chemotherapy Infusion Pump. The AutoEx pump is engineered for either continuous or intermittent delivery of chemotherapy drugs to patients afflicted with malignancies. Its objective is to sustain optimal drug concentration in the bloodstream, thereby improving the efficacy of cancer treatment while simultaneously mitigating undesirable side effects. This device incorporates a dual CPU control system and a dual power supply, ensuring high precision in drug administration. Such a design enhances both patient comfort and safety during chemotherapy.

Which Key Market Players Are Investing In Expansion And Innovation Of Chemotherapy Market?

Major companies operating in the chemotherapy market include GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Chemotherapy Market?

North America was the largest region in the chemotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Chemotherapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9219&type=smp

Browse Through More Reports Similar to the Global Chemotherapy Market 2025, By The Business Research Company

Pain Management Devices And Therapies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Metabolomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Isothermal Nucleic Acid Amplification Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Chemotherapy Market Evolve in Terms of Growth and Size by 2029?

The market for chemotherapy has experienced robust growth over the past few years. It is projected to escalate from $34 billion in 2024 to $37.27 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. Factors such as increasing cancer cases, advancement in diagnosis techniques, innovative drug discovery, active clinical trials, better healthcare access, and awareness campaigns have fueled the growth during the historical period.

Anticipations of a swift escalation are being made for the size of the chemotherapy market in the years to come. An increase to “$60.31 billion by 2029 with a compound annual growth rate (CAGR) of 12.8%” is being projected. This predicted growth for the forecasted years is attributed to various factors such as integration of immunotherapy, incorporation of biosimilars, expansion in emerging markets, genomic profiling, advances in supportive care, and regulatory assistance. Key trends for the forecasted period encompass technological innovations in healthcare, custom-tailored medicine, continued research in oncology, incorporation of artificial intelligence (AI), progress in nanotechnology, and administration of chemotherapy at home.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

What factors are expected to fuel Chemotherapy market growth in the coming years?

The rise in cancer incidence is predicted to escalate the expansion of the chemotherapy market. The term cancer describes a disorder where some cells in the body multiply unrestrained and migrate to other regions. Chemotherapy involves the use of potent medicinal compounds either in unison or individually to eliminate rapidly multiplying cancer cells. The surge in cancer cases will in turn increase the necessity for chemotherapy. For example, the American Cancer Society Inc., a non-profit health organization located in the US, predicts 1.9 million new cancer diagnoses in the US in 2023, marking a rise from 1.8 million new cases recorded in 2020. In the US, it is projected that there would be 609,820 deaths due to cancer in 2023, in contrast to an estimation of 606,520 Americans dying from cancer in 2020. Hence, the escalating occurrence of cancer is propelling the chemotherapy market.

What Are The Key Findings From The Segmentation Analysis Of The Chemotherapy Market?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

What Upcoming Trends Are Expected To Impact The Chemotherapy Market Globally?

Key players in the chemotherapy market are striving to differentiate themselves by developing innovative products such as chemotherapy infusion pumps. These devices administer chemotherapy drugs directly into the bloodstream via an intravenous line, allowing for a gradual and constant drug infusion. One example is Shanghai MicroPort Lifesciences Co. Ltd., which in March 2022, attained approval from China’s National Medical Products Administration (NMPA) to market their AutoEx Chemotherapy Infusion Pump. This pump, used for either continuous or intermittent drug infusion in cancer patients, seeks to sustain optimal drug levels in the blood to enhance treatment efficiency while mitigating undesired side effects. The device comes with a dual CPU control system and an alternate power supply to ensure precise drug delivery, thereby increasing patient comfort and safety during treatment.

What Are The Most Active Companies In The Chemotherapy Market Today?

Major companies operating in the chemotherapy market include GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Which Regional Markets Are Attracting The Most Investment In Chemotherapy?

North America was the largest region in the chemotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9219&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model